Physician profile
Gorav Ailawadi
NPI 1710196894
$434,258.32
in general payments reported to CMS, 2019-2025
26 companies · $109K in 2025
The $109K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $15K · 2021: $29K · 2022: $54K · 2023: $57K · 2024: $120K · 2025: $109K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $163K · Travel and Lodging: $62K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $162,670.59 |
| Travel and Lodging | $61,774.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,506.25 |
| Food and Beverage | $14,570.60 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $120,273.68 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Arthrex, INC. | $83,043.41 | 2023-2025 | Arthrex |
| Medtronic, INC. | $75,743.81 | 2021-2025 | Avalus, Simulus, Penditure |
| Philips North America LLC | $43,586.83 | 2022-2024 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided |
| Abbott Laboratories | $37,222.76 | 2019-2025 | Epic, Tendyne, Trifecta |
| W. L. Gore & Associates, INC. | $34,443.31 | 2019-2024 | Product In Development, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic Vascular, INC. | $15,520.16 | 2019-2020 | |
| Admedus Corporation | $12,000.00 | 2019-2020 | |
| Jenavalve Technology, INC. | $4,463.49 | 2021-2025 | Jenavalve Pericardial Tavr System |
| Artivion, INC. | $2,127.74 | 2021 | |
| Corcym INC | $1,843.21 | 2024 | Perceval |
| Ancora Heart, INC. | $1,221.60 | 2019-2020 | |
| Ethicon US, LLC | $966.91 | 2019-2025 | Vistaseal, Prolene |
| Livanova USA, INC. | $418.27 | 2019-2021 | |
| Atricure, INC. | $289.34 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $256.56 | 2023-2025 | |
| Enablecv INC. | $202.09 | 2025 | |
| Bolton Medical INC | $183.84 | 2023 | Treo Abdominal Stent-Graft System |
| Baxter Healthcare | $131.95 | 2021-2024 | Preveleak |
| Medistim USA, INC. | $105.00 | 2019 | |
| Osprey Medical INC | $88.61 | 2020 | |
| Kestra Medical Technology Services, INC. | $80.34 | 2025 | Assure Wcd |
| Tricoast Surgical Solutions LLC | $26.63 | 2024 | |
| Hemosonics LLC | $18.78 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gorav Ailawadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.